Based on 5 analysts giving stock ratings to Aldeyra Therapeutics Inc in the past month.
In the current month, ALDX has received 2 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. ALDX average Analyst price target in the last month is 7.167.
Based on analysts' estimates, ALDX EPS is projected to reach -0.076 in FY2026Q4, following reported EPS of -0.062 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.06, while Aldeyra Therapeutics IncALDX's earnings per share (EPS) for the previous quarter was USD -0.09. EPS for the next quarter is expected at USD -0.08.